Clinical Trial Update: Universal CAR-T Cell Therapy for Refractory Lupus Nephritis [EARLY_Phase 1]

View source ↗

Summary

An early-phase trial evaluating universal CAR-T cell therapy for refractory lupus nephritis is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis

Drugs mentioned

• Universal CAR-T Cell Therapy

Snippet

Sponsor: Bioray Laboratories | Conditions: Lupus Nephritis | EARLY_Phase 1 | Status: NOT_YET_RECRUITING